Edition:
United States

Eleven Biotherapeutics Inc (EBIO.OQ)

EBIO.OQ on NASDAQ Stock Exchange Global Market

0.66USD
3:59pm EST
Change (% chg)

$0.01 (+0.86%)
Prev Close
$0.65
Open
$0.65
Day's High
$0.67
Day's Low
$0.65
Volume
50,801
Avg. Vol
105,122
52-wk High
$2.53
52-wk Low
$0.63

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.369
Jun '17 0.00 -0.296
Mar '17 0.43 -0.246
FY 2016 Dec '16 0.82 -0.145
Sep '16 28.65 0.910
Jun '16 0.28 -0.327
Mar '16 0.23 -0.386
FY 2015 Dec '15 0.56 -0.528
Sep '15 0.07 -0.501
Jun '15 0.11 -0.362
Mar '15 0.24 -0.363
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 190.77 35.50
P/E High - Last 5 Yrs. 21.95 277.36 45.22
P/E Low - Last 5 Yrs. 21.95 92.80 24.21
Beta 3.09 0.82 0.91
Price to Sales (TTM) 16.56 117.72 5.89
Price to Book (MRQ) 0.94 21.83 5.66
Price to Tangible Book (MRQ) -- 25.81 7.25
Price to Cash Flow (TTM) -- 103.69 24.38
% Owned Institutions 24.73 5.72 1.41

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.49
Dividend Yield - 5 Year Avg -- 0.26 2.05
Dividend 5 Year Growth Rate -- 2.00 5.25
Payout Ratio(TTM) -- 98.06 46.15

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -100.00 -3.06 6.81
Sales (TTM) vs TTM 1 Yr. Ago -95.79 30.14 5.59
Sales - 5 Yr. Growth Rate -- 33.20 10.23
EPS (MRQ) vs Qtr. 1 Yr. Ago -140.52 -148.11 7.98
EPS (TTM) vs TTM 1 Yr. Ago -219.70 -- --
EPS - 5 Yr. Growth Rate -- 43.94 10.93
Capital Spending - 5 Yr. Growth Rate -- 41.00 15.14

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.80 2.55
Current Ratio (MRQ) 2.75 5.70 3.57
LT Debt to Equity (MRQ) 0.00 14.63 13.37
Total Debt to Equity (MRQ) 0.00 17.10 19.35
Interest Coverage (TTM) -5.00 -135.87 44.50

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 44.20 54.91
Gross Margin - 5 Yr. Avg. -- 55.70 52.46
EBITD Margin (TTM) -2,079.68 -- --
EBITD - 5 Yr. Avg -286.84 -219.33 15.51
Operating Margin (TTM) -2,029.52 -637.28 6.68
Operating Margin - 5 Yr. Avg. -292.97 -236.27 10.99
Pre-Tax Margin (TTM) -2,080.64 -607.21 7.52
Pre-Tax Margin - 5 Yr. Avg. -299.28 -236.41 11.40
Net Profit Margin (TTM) -2,081.04 -604.71 3.74
Net Profit Margin - 5 Yr. Avg. -299.29 -239.71 7.69
Effective Tax Rate (TTM) -- 15.46 24.27
Effective Tax Rate - 5 Yr. Avg. -- 19.04 24.07

Efficiency

  Company industry sector
Revenue/Employee (TTM) 36,765 21,870,754 851,754,569
Net Income/Employee (TTM) -765,088 -1,731,043 99,535,212
Receivable Turnover (TTM) -- 26.18 6.13
Inventory Turnover (TTM) -- 2.65 3.55
Asset Turnover (TTM) 0.02 0.43 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -34.26 -9.33 11.32
Return on Assets - 5 Yr. Avg. -62.31 0.11 12.28
Return on Investment (TTM) -36.85 -11.61 14.44
Return on Investment - 5 Yr. Avg. -72.36 3.32 16.08
Return on Equity (TTM) -88.92 -35.87 16.05
Return on Equity - 5 Yr. Avg. -- 5.69 17.28
  1 Year 3 Year 5 Year
Sales % 2,928.38 182.20 --
EPS (TTM) % 104.94 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Eleven Biotherapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 34.15%
# of Holders: 33
Total Shares Held: 10,872,043
3 Mo. Net Change: 2,983,687
# New Positions: 6
# Closed Positions: 7
# Increased Positions: 7
# Reduced Positions: 14
# Net Buyers: -7
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.